Medical Device News Magazine

Christopher J. Calhoun

Escaping the “Valley of Death”— The Funding Process for Biotechnology Companies

Innovative biotechnology companies have the potential to transform healthcare, developing new therapies that may improve, as well as extend, the lives of patients. Delivering on this promise is an epic journey that may take one to two decades, unimaginable amounts of cash, and surviving the notorious valley of death. Read what Christopher J. Calhoun, Chairman & CEO of PARACRINE has to say.
- Advertisement -spot_img

Latest News

Europe $3.53 Bn Sleep Apnea Devices Markets 2024-2032 by Types, Therapeutic Devices, Diagnostic Devices, End User, and Company Analysis

Europe sleep apnea devices market turned into US$ 1.81 billion in 2023 and is expected to reach US$ 3.53 billion by 2032, with a CAGR of 7.70% from 2024 to 2032.
- Advertisement -spot_img